New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
06:08 EDTPMCPharMerica upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse upgraded PharMerica citing improving fundamentals, capital deployment opportunities, and valuation. Price target raised to $30 from $19.
News For PMC From The Last 14 Days
Check below for free stories on PMC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for PMC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use